Media Overview
Media Overview
Search
Our Stories
Our Stories
See our Locations
We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations.
FIBRONEER™ trials for IPF, other progressive fibrosing ILDs
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
Targeting HER2 in cancer
Our cancer researchers share insights into the discovery of our investigational HER2-selective tyrosine kinase inhibitor.
Human Health
Human Health
Boehringer’s unique approach to innovation
Boehringer’s unique approach to driving patient-centric innovation
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Our Partners: ViraTherapeutics
Our Partners: ViraTherapeutics
A Unique Bond: human and animal health
A Unique Bond: human and animal health
Companion Animals & Horses
Companion Animals & Horses
Human Health Innovation
Pipeline
Our Innovation Prize | Partnering
Established in 2015 and jointly sponsored by BI and the BI Venture Fund, the prize allows recipients to focus on development of breakthrough medicines.
Partnering Days
Partnering Days
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Across Cancer Types
Across Cancer Types
Tackling Health Disparities and Inequities for Women With Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care
Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care
Swine
Swine
Oncology & Cancer Immunology
Oncology & Cancer Immunology
Oncology & Cancer Immunology
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in oncology.
Gastrointestinal Cancers
Gastrointestinal Cancers
Lung Cancer
Lung Cancer
How Simulation is Changing the Game in Biotherapeutic Drug Development
How Simulation is Changing the Game in Biotherapeutic Drug Development
Respiratory Diseases
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.
Expanded Access Programs
Expanded Access Programs